Skip to content

Longterm-Evaluation of Vitelene® Against Standard

Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01713062
Acronym
VITAS
Enrollment
400
Registered
2012-10-24
Start date
2012-01-31
Completion date
2030-06-30
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Osteoarthritis, Hip

Brief summary

The purpose of this randomised prospective multicenter longterm study is to evaluate the survival rate of the implant, wear and periprosthetic osteolysis of highly cross-linked polyethylene with and without addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X) in Total Hip Arthroplasty.

Interventions

DEVICEVitelene

THA

DEVICEXLPE

THA

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Inclusion: * Minimum age: 18 years * Maximum age: 75 years * Indication of cementless THA * Approval of study participation and treatment according to study protocol * Physical and mental willingness of adhering to clinical and radiological follow up Exclusion: * Patient is not able to join follow up * Increased risk of anaesthesia according to the American Society of Anesthesiology: ASA IV * Tumor disease * Alcohol and drug dependency * Permanent cortisone therapy * Clinical relevant infections * Pregnancy and planned pregnancy * Previous interventions like adjustment-osteotomy, treatment of fractures or THA on affected side * Acute fractures of the affected hip joint * Patients with bone quality, which doesn´t allow a cementless treatment * Requirements of clinical relevant deformities (condition after preoperation or bone fracture, leg length discrepancy \> 30 mm, Offset-reduction about \> 30 mm) * Small acetabular treatments with 28 mm heads * Treatments without using ceramic heads * Treatments which require neck prolonging components

Design outcomes

Primary

MeasureTime frameDescription
Analysis and measurement of oxidation index of the Polyethylene Inlay after RevisionOxidation index is assessed in case of loosening and revision within 15 yearsThe Oxidation index is measured after explantation in case of loosening of the inlay

Secondary

MeasureTime frameDescription
Manifest radiological osteolysesMeasured radiologically after 1, 5, 10 and 15 years
Traceable wear of polyethylene over 0.5 mmMeasured radiologically after 1, 5, 10 and 15 years
Clinical OutcomeAfter 1, 5, 10 and 15 yearsClinical Outcome measured by Harris Hip Score (HHS), Hip disability and osteoarthritis outcome score(HOOS), University of California at Los Angeles Score (UCLA)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026